BioAtla Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2	2	11	-	-	0.25
Revenue Growth	-81.82%	-81.82%	-	-	-	-41.73%
Cost of Revenue	34.9	43.07	63.1	103.73	79.35	58.27
Gross Profit	-32.9	-41.07	-52.1	-103.73	-79.35	-58.02
Selling, General & Admin	17	17.63	21.85	25.96	28.79	38.42
Operating Expenses	17	17.63	21.85	25.96	28.79	38.42
Operating Income	-49.9	-58.71	-73.94	-129.69	-108.14	-96.44
Interest Expense	-	-	-	-	-	-0
Interest & Investment Income	0.48	0.84	3.37	6.31	1.65	0.35
Other Non Operating Income (Expenses)	-0.1	-1.15	0.8	-0.09	0.01	0
EBT Excluding Unusual Items	-49.52	-59.01	-69.78	-123.46	-106.48	-96.09
Merger & Restructuring Charges	-1.1	-0.6	-	-	-	-
Other Unusual Items	-	-	-	-	-	0.69
Pretax Income	-50.62	-59.61	-69.78	-123.46	-106.48	-95.4
Earnings From Continuing Operations	-50.62	-59.61	-69.78	-123.46	-106.48	-95.4
Net Income	-50.62	-59.61	-69.78	-123.46	-106.48	-95.4
Net Income to Common	-50.62	-59.61	-69.78	-123.46	-106.48	-95.4
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	1	1	1	1	1	1
Shares Outstanding (Diluted)	1	1	1	1	1	1
Shares Change	23.33%	21.11%	1.67%	22.73%	12.63%	310.07%
EPS (Basic)	-40.15	-50.66	-71.83	-129.21	-136.77	-138.02
EPS (Diluted)	-40.15	-50.66	-71.83	-129.21	-136.77	-138.02
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-37.18	-48.2	-71.94	-104.11	-90.69	-63.14
Free Cash Flow Per Share	-29.49	-40.97	-74.05	-108.96	-116.48	-91.34
Operating Margin	-2494.95%	-2935.25%	-672.21%	-	-	-38576.00%
Profit Margin	-2530.85%	-2980.35%	-634.33%	-	-	-38160.80%
Free Cash Flow Margin	-1859.15%	-2410.20%	-653.96%	-	-	-25255.20%
EBITDA	-49.59	-58.33	-73.02	-128.47	-106.94	-95.11
D&A For EBITDA	0.31	0.37	0.93	1.22	1.2	1.33
EBIT	-49.9	-58.71	-73.94	-129.69	-108.14	-96.44

SEC Filings: 10-K · 10-Q